1. Home
  2. SYM vs RYTM Comparison

SYM vs RYTM Comparison

Compare SYM & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Symbotic Inc.

SYM

Symbotic Inc.

N/A

Current Price

$51.07

Market Cap

7.5B

Sector

Industrials

ML Signal

N/A

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

N/A

Current Price

$89.97

Market Cap

6.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SYM
RYTM
Founded
2005
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
6.4B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
SYM
RYTM
Price
$51.07
$89.97
Analyst Decision
Hold
Strong Buy
Analyst Count
13
14
Target Price
$57.31
$129.43
AVG Volume (30 Days)
1.3M
715.6K
Earning Date
05-06-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.34
EPS
0.02
N/A
Revenue
$2,246,922,000.00
N/A
Revenue This Year
$24.75
$57.46
Revenue Next Year
$27.90
$85.60
P/E Ratio
$2,486.88
N/A
Revenue Growth
25.65
N/A
52 Week Low
$16.32
$45.91
52 Week High
$87.88
$122.20

Technical Indicators

Market Signals
Indicator
SYM
RYTM
Relative Strength Index (RSI) 40.54 39.84
Support Level $48.60 $85.59
Resistance Level $63.57 $96.92
Average True Range (ATR) 2.70 4.86
MACD -0.27 -0.29
Stochastic Oscillator 39.27 22.30

Price Performance

Historical Comparison
SYM
RYTM

About SYM Symbotic Inc.

Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: